ArticleFrontiers in endocrinology2022

PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer.

Jeanesse Scerri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.